Cargando…

High-Dose Oral Amiodarone for Cardioversion of Atrial Fibrillation: A Case Report

With the rising prevalence of atrial fibrillation (AF), it has become a global health problem with increasing complications and high medical costs. Here, we describe the case of a 52-year-old woman with chest discomfort and frequent palpitations for the last few months. A careful clinical and instru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reynaldo, Giovanni, Hamonangan, Rachmat, Naomi, Pingkan, Widjanarko, Nicolas Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416672/ https://www.ncbi.nlm.nih.gov/pubmed/37575716 http://dx.doi.org/10.7759/cureus.41766

Ejemplares similares

Tolerance of High-Dose Oral Amiodarone for Cardioversion of Atrial Flutter
por: Le, Vincent K., et al.
Publicado: (2022)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Rare Coronary Embolism Secondary to Cardioversion of Atrial Fibrillation
por: Alkhatib, Deya, et al.
Publicado: (2022)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

The Outcome of Electrical Cardioversion in Hyperthyroid Induced Atrial Fibrillation
por: Shah, Hriday, et al.
Publicado: (2023)

Relationship Between Atrial Fibrillation Recurrence and Frontal QRS-T Angle After Effective Cardioversion
por: Özen, Kaya, et al.
Publicado: (2023)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
por: Wybraniec, Maciej T., et al.
Publicado: (2023)

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Myocardial perfusion scintigraphy before and after cardioversion for atrial fibrillation: Recovery of quantitative parameters
por: Rietbergen, Daphne D. D., et al.
Publicado: (2010)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022)

An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis
por: Zaki, Hany A, et al.
Publicado: (2022)

Electrical Cardioversion for Wide Complex Tachycardia
por: Roka, Abhishek, et al.
Publicado: (2019)

Amiodarone-Induced Myxedema Coma
por: Raeouf, Armaghan, et al.
Publicado: (2020)

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
por: Relander, Arto, et al.
Publicado: (2021)

Acute Multi-Organ Toxicity During 24-Hour Dosing of Intravenous Amiodarone: A Case Report
por: Liwag, Terrin, et al.
Publicado: (2022)

A Refractory Case of Amiodarone Thyrotoxicosis
por: Fonseca, Marta, et al.
Publicado: (2022)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

Acute Fulminant Hepatic Failure and Renal Failure Induced by Oral Amiodarone: A Case Report and Literature Review
por: Campbell, Natasha, et al.
Publicado: (2020)

Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
por: Naydenov, Stefan, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Proarrhythmia in a Patient With Heart Failure on Therapy With Amiodarone
por: Semerdzhieva, Niya E, et al.
Publicado: (2021)

Thyroid Storm in a Patient on Chronic Amiodarone Treatment
por: Raza, Muhammad Ali, et al.
Publicado: (2022)

Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
por: Sandhu, Osama, et al.
Publicado: (2020)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Prolonged Jaundice Secondary to Amiodarone Use: A Case Report and Literature Review
por: Bratton, Hunter, et al.
Publicado: (2019)

Anaphylactic Shock as a Rare Side Effect of Intravenous Amiodarone
por: Batool, Aisha, et al.
Publicado: (2022)

Treating Supraventricular Tachycardia With Amiodarone in a Patient With Ebstein’s Anomaly
por: Alnami, Mohammed Y, et al.
Publicado: (2023)

Obesity and Atrial Fibrillation: Should We Screen for Atrial Fibrillation in Obese Individuals? A Comprehensive Review
por: Ghattas, Kyrillos N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0v6n3ojh4jmt9o0s753dcrhnp6